Tower Research Capital LLC (TRC) - LUMOS PHARMA INC ownership

LUMOS PHARMA INC's ticker is LUMO and the CUSIP is 55028X109. A total of 40 filers reported holding LUMOS PHARMA INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of LUMOS PHARMA INC
ValueSharesWeighting
Q3 2023$6,376
+28.5%
1,932
+28.5%
0.00%
Q2 2023$4,960
+44990.9%
1,503
-53.2%
0.00%
Q1 2023$11
+10.0%
3,211
+14.8%
0.00%
Q4 2022$10
-100.0%
2,797
+8.3%
0.00%
Q3 2022$23,000
-11.5%
2,582
-21.3%
0.00%
-100.0%
Q2 2022$26,000
+2500.0%
3,280
+5025.0%
0.00%
Q1 2022$1,0000.0%64
-25.6%
0.00%
Q4 2021$1,00086
+8500.0%
0.00%
Q3 2021$0
-100.0%
1
-99.2%
0.00%
Q2 2021$1,000
-66.7%
123
-48.3%
0.00%
Q1 2021$3,000
-66.7%
238
-77.2%
0.00%
-100.0%
Q1 2020$9,0001,0430.00%
Other shareholders
LUMOS PHARMA INC shareholders Q4 2021
NameSharesValueWeighting ↓
PVG ASSET MANAGEMENT CORP 10,175$70,512,0000.26%
Minerva Advisors LLC 34,015$236,0000.14%
Investors Financial Group, LLC 30,600$212,0000.10%
Lion Point Capital, LP 51,205$354,0000.10%
NEA Management Company, LLC 376,916$2,612,0000.05%
Wealth Advisors of Iowa, LLC 11,699$81,0000.04%
Paladin Advisory Group, LLC 4,382$30,0000.02%
Marquette Asset Management, LLC 13,315$92,0000.02%
Blackstone Inc. 468,145$3,244,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 47,643$331,0000.01%
View complete list of LUMOS PHARMA INC shareholders